ILOSONE Overview
ERYTHROMYCIN ESTOLATE
- SUSPENSION; ORAL: EQ 125MG BASE/5ML
- FOR SUSPENSION; ORAL: EQ 125MG BASE/5ML
- SUSPENSION; ORAL: EQ 250MG BASE/5ML
- TABLET, CHEWABLE; ORAL: EQ 125MG BASE
- TABLET; ORAL: EQ 500MG BASE
- CAPSULE; ORAL: EQ 250MG BASE
Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).
| FDA application | Dosage Form | Strength | Marketing Status | Company |
|---|---|---|---|---|
| NDA #050010 | SUSPENSION; ORAL | EQ 125MG BASE/5ML | Discontinued | LILLY |
| NDA #061893 | FOR SUSPENSION; ORAL | EQ 125MG BASE/5ML | Discontinued | DISTA |
| NDA #061894 | SUSPENSION; ORAL | EQ 250MG BASE/5ML | Discontinued | LILLY |
| NDA #061895 | TABLET, CHEWABLE; ORAL | EQ 125MG BASE | Discontinued | DISTA |
| NDA #061896 | TABLET; ORAL | EQ 500MG BASE | Discontinued | LILLY |
| NDA #061897 | CAPSULE; ORAL | EQ 250MG BASE | Discontinued | LILLY |
